NASDAQ:XTLB

Xtl Biopharmaceuticals Stock Insider Trading

etoro logo Buy XTLB
*Your capital is at risk
$2.26
-0.0300 (-1.31%)
At Close: Jun 03, 2026

XTL Biopharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 14.59M and sold 86.27M XTLB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 14.59M shares
Sell 86.27M shares
82% Buy Activity
Moderate Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 18, 2026
Buy
Options
Hillel Fain Osnat
Director
Director 1 000 000
Value: $14.0K
Mar 18, 2026
Buy
Common Stock
J-Other
Segal Niv
Insider
Other 0
Value: $0
Nov 19, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 9 600 000
Value: $1.47M
Nov 19, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 9 600 000
Value: $1.47M
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 24 681 360
Value: $3.48M
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 2 696 450
Value: $412.0K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 29 740
Value: $5K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 400 000
Value: $64.6K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 1 943 250
Value: $273.8K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 400 000
Value: $61.1K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 299 570
Value: $45.8K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 299 570
Value: $45.8K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 400 000
Value: $61.1K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 1 943 250
Value: $273.8K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 400 000
Value: $64.6K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 29 740
Value: $5K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 2 696 450
Value: $412.0K
Nov 18, 2008
Sell
Ordinary Shares
S-Sale
Edelman Joseph
10 Percent Owner
10% Owner 24 681 360
Value: $3.48M
Nov 10, 2008
Buy
Options to Purchase Ordinary Shares
Zuerblis Kenneth J
Director
Director 300 000
Value: $59.4K
Nov 10, 2008
Buy
OPTIONS TO PURCHASE ORDINARY SHARES
Rudman Samuel
Director
Director 300 000
Value: $59.4K
Nov 10, 2008
Buy
Options to Purchase Ordinary Shares
Good Jennifer L
Director
Director 300 000
Value: $59.4K
Nov 10, 2008
Buy
Options to Purchase Ordinary Shares
Good Jennifer L
Director
Director 300 000
Value: $59.4K
Nov 10, 2008
Buy
OPTIONS TO PURCHASE ORDINARY SHARES
Rudman Samuel
Director
Director 300 000
Value: $59.4K
Nov 10, 2008
Buy
Options to Purchase Ordinary Shares
Zuerblis Kenneth J
Director
Director 300 000
Value: $59.4K
Oct 10, 2008
Buy
Options to Purchase Ordinary Shares
A-Award
Weiner Ben-zion
Director
Director 300 000
Value: $59.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT XTL BIOPHARMACEUTICALS LTD.
XTL Biopharmaceuticals
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCD...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE